Education
About Us
Working with TipRanks
Follow Us
Neogen Chemicals Ltd. (IN:NEOGEN)
:NEOGEN
NEOGEN Stock Chart & Stats
₹1156.90
₹9.65(0.45%)
At close: 4:00 PM EST
₹1156.90
₹9.65(0.45%)
Day’s Range― - ―
52-Week Range₹978.00 - ₹1,867.95
Previous CloseN/A
Volume22.32K
Average Volume (3M)9.36K
Market Cap
₹35.47B
Enterprise Value₹46.65B
Total Cash (Recent Filing)₹5.00B
Total Debt (Recent Filing)₹11.32B
Price to Earnings (P/E)211.5
Beta1.35
Next Earnings
May 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.09%
Share Statistics
EPS (TTM)1.40
Shares Outstanding26,381,674
10 Day Avg. Volume1,157
30 Day Avg. Volume9,357
Financial Highlights & Ratios
PEG Ratio-22.51
Price to Book (P/B)5.41
Price to Sales (P/S)5.49
P/FCF Ratio-35.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹2,001.00Price Target Upside72.96% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)10.79
Revenue Forecast (FY)₹8.46B
Bulls Say, Bears Say
Bulls Say
Diversified End‑market ExposureNeogen supplies bromine- and lithium-based intermediates across pharmaceuticals, agrochemicals, specialty materials and energy-storage supply chains. This market diversification reduces single-sector cyclicality and provides structural exposure to multi-year growth in batteries and specialty chemistry.
Improving Operating Margins And Revenue GrowthReported strong revenue growth alongside improving EBIT/EBITDA margins indicates operational progress and better mix toward higher-value intermediates. Sustained margin improvement reflects scalable manufacturing and pricing power in specialty products, supporting durable profitability gains if maintained.
Growing Equity Base / Balance Sheet SupportA steadily increasing equity base strengthens the company’s capacity to fund capex, support contract manufacturing commitments, and absorb shocks. Higher shareholder equity improves creditor confidence and underpins long-term strategic investments despite other leverage considerations.
Bears Say
Volatile Cash Flow & Negative Free Cash FlowNegative and volatile free cash flows impair Neogen’s ability to self-fund expansion, repay debt, and invest in higher-margin capacity. Persistent FCF weakness increases reliance on external financing, raising execution risk for multi-year product development and capital projects.
Relatively High LeverageElevated debt levels raise interest and refinancing sensitivity and limit financial flexibility. In an industry requiring periodic capex and raw-material funding, high leverage magnifies downside risk from demand slowdowns or input-cost inflation, constraining strategic options over months.
Low Net Profit MarginsDespite healthy gross margins, low net margins indicate SG&A, financing, or non-operational costs are eroding returns. This compresses retained earnings and ROIC, limiting the company’s long-term capacity to reinvest, pay down debt, or generate durable shareholder returns.
Neogen Chemicals Ltd. News
NEOGEN FAQ
What was Neogen Chemicals Ltd.’s price range in the past 12 months?
Neogen Chemicals Ltd. lowest stock price was ₹978.00 and its highest was ₹1867.95 in the past 12 months.
What is Neogen Chemicals Ltd.’s market cap?
Neogen Chemicals Ltd.’s market cap is ₹35.47B.
When is Neogen Chemicals Ltd.’s upcoming earnings report date?
Neogen Chemicals Ltd.’s upcoming earnings report date is May 25, 2026 which is in 71 days.
How were Neogen Chemicals Ltd.’s earnings last quarter?
Neogen Chemicals Ltd. released its earnings results on Feb 11, 2026. The company reported ₹1.4 earnings per share for the quarter, missing the consensus estimate of ₹2.733 by -₹1.333.
Is Neogen Chemicals Ltd. overvalued?
According to Wall Street analysts Neogen Chemicals Ltd.’s price is currently Undervalued.
Does Neogen Chemicals Ltd. pay dividends?
Neogen Chemicals Ltd. pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.09%. See more information on Neogen Chemicals Ltd. dividends here
What is Neogen Chemicals Ltd.’s EPS estimate?
Neogen Chemicals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neogen Chemicals Ltd. have?
Neogen Chemicals Ltd. has 26,381,674 shares outstanding.
What happened to Neogen Chemicals Ltd.’s price movement after its last earnings report?
Neogen Chemicals Ltd. reported an EPS of ₹1.4 in its last earnings report, missing expectations of ₹2.733. Following the earnings report the stock price went down -0.898%.
Which hedge fund is a major shareholder of Neogen Chemicals Ltd.?
Currently, no hedge funds are holding shares in IN:NEOGEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Neogen Chemicals Ltd.
Neogen Chemicals Limited manufactures and sells specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds, unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; inorganic bromine compounds and lithium salts; grignard reagents; and advance intermediates. The company also provides custom synthesis and manufacturing services. It serves pharmaceutical, agrochemical, engineering, flavour and fragrance, electronic-chemical, refrigeration, construction chemicals, pharmaceutical, and specialty polymer industries, as well as heating, ventilation, and air-conditioning industries. The company also exports its products to 28 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.
NEOGEN Stock 12 Month Forecast
Average Price Target
₹2,001.00
▲(72.96% Upside)
Technical Analysis
Balaji Amines Limited
―
Hikal Limited
―
Rossari Biotech Ltd
―
Thirumalai Chemicals Limited
―
UFlex Limited
―